Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2018 Oct 17;9(11):1059.
doi: 10.1038/s41419-018-1091-y.

miR-3178 inhibits cell proliferation and metastasis by targeting Notch1 in triple-negative breast cancer

Affiliations

miR-3178 inhibits cell proliferation and metastasis by targeting Notch1 in triple-negative breast cancer

Peng Kong et al. Cell Death Dis. .

Abstract

Triple-negative breast cancer (TNBC) has a poorer outcome than other subtypes of breast cancer, and the discovery of dysregulated microRNA (miRNA) and their role in tumor progression has provided a new avenue for elucidating the mechanism involved in TNBC. In this study, we identified that miR-3178 was significantly reduced in TNBC, and the low miR-3178 expression correlated with poor overall survival in TNBC but not in non-TNBC. The ectopic overexpression of miR-3178 suppressed TNBC cell proliferation, invasion, and migration by inhibiting the epithelial-to-mesenchymal (EMT) transition. Notch1 was validated as the direct target gene of miR-3178, which was confirmed by the dual-luciferase reporter assay. miR-3178 decreased the expression of Notch1 and restoration of Notch1 expression attenuated the inhibitory effects of miR-3178 on cell proliferation, metastasis, and the EMT in TNBC. miR-3178 inhibited cell proliferation and metastasis by targeting Notch1 in TNBC, and the restoration of miR-3178 might be a potential therapeutic strategy for TNBC.

PubMed Disclaimer

Conflict of interest statement

The authors declare that they have no conflict of interest.

Figures

Fig. 1
Fig. 1. miR-3178 expression level was downregulated in TNBC.
a The strategy for detecting different expression miRNAs between TNBC and non-TNBC in TCGA database. b Scatter plot of the different expression miRNAs. The points under the red line represent the differentially expressed miRNAs with statistical significance. c Expression levels of miR-3178 in TNBC and non-TNBC in TCGA. d Expression levels of miR-3178 in 17 TNBC and 17 non-TNBC tissues. e, f High levels of miR-3178 correlated with a better overall survival in TNBC. However, high miR-3178 expression was not associated with a better OS in non-TNBC
Fig. 2
Fig. 2. miR-3178 suppressed the cell proliferation and migration of TNBC cells.
a Cells were transfected with miR-3178 mimic lentivirus, and the expression level of miR-3178 was detected after stable transfection. b Cell proliferation was evaluated by the CCK-8 assay at 24, 48, 72, and 96 h. c The effect of miR-3178 on mRNA expression levels of cell proliferation and cycle-related genes was detected by qRT-PCR. d Colony formation assay showed miR-3178 reduced colony numbers. The wound healing assay (e) and transwell invasion assay (f) were performed to detect the effects of miR-3178 on TNBC migration and invasion, scale bars: 300 μm (e) and 100 μm (f). ***P < 0.001, *P < 0.05
Fig. 3
Fig. 3. miR-3178 inhibited the EMT in TNBC cells.
qRT-PCR (a) and western blot (b) analysis showed miR-3178 increased E-cadherin levels, and inhibited vimentin and N-cadherin levels in SUM-1315 and MDA-MB-231. c miR-3178 downregulated the mRNA expression levels of Snail and Slug, transcription factors that directly regulate the EMT. d Snail and Slug protein expression in SUM-1315 and MDA-MB-231 transfected with miR-3178 mimics. *P < 0.05
Fig. 4
Fig. 4. Notch1 was a direct downstream target of miR-3178.
a The luciferase reporter constructs that had either a WT-notch1-3′-UTR or mut-notch1-3′-UTR sequence of the miR-3178-binding site. b Luciferase reporter activity revealed miR-3178 suppressed Notch1 3′UTR luciferase activity of wide-type constructs in SUM-1315 and MDA-MB-231 cells. c qRT-PCR analysis showed that miR-3178 mimics decrease Notch1 and NF-κB (a downstream factor of Notch1) mRNA level. d Notch1 and NF-κB protein expression in SUM-1315 and MDA-MB-231 transfected with miR-3178 mimics. * P < 0.05
Fig. 5
Fig. 5. Expression of Notch1 attenuated inhibition of cancer cell proliferation by miR-3178 in TNBC cells.
Cells were transfected with Notch1 overexpression plasmid (p-Notch1), and the mRNA and protein expression of Notch1 and NF-κB protein level was detected by qRT-PCT (a) and western blot (b). c CCK8 assay showed the inhibition of cell proliferation by miR-3178 was reversed by p-Notch1. d p-Notch1restoredthe mRNA levels of Ki-67, cyclinD1, and cyclin E1, which were inhibited by miR-3178 mimics. e p-Notch1 reversed the inhibitory effects of miR-3178 on colony formation. **P < 0.01, *P < 0.05
Fig. 6
Fig. 6. miR-3178 regulated Notch1-mediated migration and the EMT through Snail1 in TNBC cells.
The wound healing (a) and transwell assay (b) showed the inhibition of miR-3178 on cell migration and invasion was attenuated after restoring the expression of Notch1 by p-Notch1, scale bars: 300 μm (a) and 100 μm (b). c p-Notch1 reversed the effect of miR-3178 on the mRNA expression of the EMT markers and Snail. d p-Notch1 restored the protein expression of the EMT markers and Snail. *** P <0.001, ** P <0.01, * P < 0.05
Fig. 7
Fig. 7. miR-3178 inhibited tumor growth in a nude mouse model of TNBC.
a MDA-MB-231 and SUM-1315 cells transfected with miR-3178, miR-3178/p-Notch1, miR-3178/p-NC, and m-NC were subcutaneously implanted into nude mice. The tumor weight of miR-3178 and miR-3178/p-NC was lower than that with m-NC and miR-3178/p-Notch1. b miR-3178 significantly decreased tumor volume compared with m-NC. miR-3178/p-Notch1 partly neutralized the inhibitory effects of miR-3178 on tumor volume. ***P< 0.001, **P< 0.01, *P < 0.05

Similar articles

Cited by

References

    1. Gluz O, et al. Triple-negative breast cancer—current status and future directions. Ann. Oncol. 2009;20:1913–1927. - PubMed
    1. Dent R, et al. Triple-negative breast cancer: clinical features and patterns of recurrence. Clin. Cancer Res. 2007;13:4429–4434. - PubMed
    1. Malorni L, et al. Clinical and biologic features of triple-negative breast cancers in a large cohort of patients with long-term follow-up. Breast Cancer Res. Treat. 2012;136:795–804. - PMC - PubMed
    1. Weigelt B, Reis-Filho JS. Histological and molecular types of breast cancer: is there a unifying taxonomy? Nat. Rev. Clin. Oncol. 2009;6:718–730. - PubMed
    1. Banerji S, et al. Sequence analysis of mutations and translocations across breast cancer subtypes. Nature. 2012;486:405–409. - PMC - PubMed

Publication types

MeSH terms